TRIM44 and Miyoshi myopathy: Given these cytogenetic abnormalities’ known impacts on clinical presentation, progression from precursor stages (MGUS, SMM) to MM, prognosis, and management strategies [26], we further examined the relationship between TRIM44 expression and these translocations.